comparison of Pamidronate and calcium-D effect on bone mineral density of renal transplant patients in Isfaha
Not Applicable
- Conditions
- End Stage Renal Disease.End-stage renal disease
- Registration Number
- IRCT138903252417N2
- Lead Sponsor
- Isfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 34
Inclusion Criteria
adult recipients more than 18 years of first or second living donor renal transplant in Isfahan renal transplantation centers.
Exclusion criteria: receiving corticosteroid 3 months prior to the renal transplantation (RTx), treating with bisphosphonates, Flouride or Calcitonin any time before RTx, hypercalcemia persisting during the first 2 weeks after RTx, history of previous parathyroidectomy, hemodynamic instability in 24 hours after RTx
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Bone mineral density. Timepoint: before and after intervention. Method of measurement: DEXA (dual energy x ray absorptiometry).
- Secondary Outcome Measures
Name Time Method